Reboxetine has no antidepressant effect at allBMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h5842 (Published 03 November 2015) Cite this as: BMJ 2015;351:h5842
- Richard Braithwaite, consultant psychiatrist1
- 1St Mary’s Hospital, Newport PO30 5TG, UK
Muzerengi and Clarke are correct to advise against the use of most antidepressants in combination with the monoamine oxidase B inhibitors, rasagiline and selegiline.1 But it …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial